If the clinician determines GLP-1 medication is not appropriate for your situation, you would not receive a prescription
On August 27, 2025, the FDA approved the first generic version of liraglutide (Saxenda) for weight loss in adults and adolescents with obesity and adults with overweight and at least one weight-related comorbid condition
If you want to avoid the insurance hurdle entirely, InjectCos cash-pay compounded semaglutide program at $249 per month gives you medical supervision, all supplies, and ongoing monitoring without waiting on a payer decision
We usually administer NAD+ on its own
For those using tirzepatide for weight management, reduced potency may manifest as weight loss plateau or diminished appetite suppression
What causes them to get out of balance is exposure to toxins and other pollutants